ERIN ESSKUCHEN: Open Payments
NPI 1790163053 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$312 in 19 payments from 6 companies in 2025. Trend: 2023 $515 · 2024 $300 · 2025 $312
Food & beverage: $312
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $170 |
| ABBVIE INC. | 3 | $45 |
| Celltrion USA Inc. | 1 | $28 |
| GENZYME CORPORATION | 1 | $27 |
| Ardelyx, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $20 |
Products named: XELJANZ, VELSIPITY, LINZESS, VEGZELMA, DUPIXENT, IBSRELA, OMVOH, CREON.
Industry payments across AL — which companies pay providers there.
